Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

April 2022

Department

Research in Review
04/20/2022
JCP Editors
J Clin Pathways. 2022;8(3):30-32. Addressing Disparities in Cancer Health, Equity, and Outcomes A panel at the 2022 Community Oncology Conference discussed how their programs address disparities in cancer care and access to cancer...
J Clin Pathways. 2022;8(3):30-32. Addressing Disparities in Cancer Health, Equity, and Outcomes A panel at the 2022 Community Oncology Conference discussed how their programs address disparities in cancer care and access to cancer...
J Clin Pathways....
04/20/2022
Journal of Clinical Pathways
Research in Review
04/20/2022
JCP Editors
J Clin Pathways. 2022;8(3):21-23. Therapeutic Targeting of BAP1/ASXL3 Sub-Complex in SCLC Investigators sought to discover the function of the oncogenic BAP1/ASXL3/BRD4 epigenetic axis in small-cell lung cancer (SCLC) by developing a...
J Clin Pathways. 2022;8(3):21-23. Therapeutic Targeting of BAP1/ASXL3 Sub-Complex in SCLC Investigators sought to discover the function of the oncogenic BAP1/ASXL3/BRD4 epigenetic axis in small-cell lung cancer (SCLC) by developing a...
J Clin Pathways....
04/20/2022
Journal of Clinical Pathways

Feature

From the Field
04/20/2022
Rouslan Kotchetkov, MD, PhD
David Susman
Erica DiMaria, MD
Lauren Gerard, MD
Derek Nay, MD
Dr Kotchetkov and colleagues assessed the pattern of B-R administration, efficacy and safety in adult patients with indolent non-Hodgkin lymphoma and mantle cell lymphoma with advanced disease and co-morbidities in the real-world setting.
Dr Kotchetkov and colleagues assessed the pattern of B-R administration, efficacy and safety in adult patients with indolent non-Hodgkin lymphoma and mantle cell lymphoma with advanced disease and co-morbidities in the real-world setting.
Dr Kotchetkov and colleagues...
04/20/2022
Journal of Clinical Pathways

Column

Editor's Page
04/20/2022
Winston Wong, PharmD, Editor-in-Chief
Dr Wong discusses features in this issue, which include insights on ACCC's 48th Annual Meeting & Cancer Business Summit, highlights from COA's Conference, and an article on real-world patterns of B-R administration in patients with iNHL and...
Dr Wong discusses features in this issue, which include insights on ACCC's 48th Annual Meeting & Cancer Business Summit, highlights from COA's Conference, and an article on real-world patterns of B-R administration in patients with iNHL and...
Dr Wong discusses features in...
04/20/2022
Journal of Clinical Pathways
Clinical Pathways GPS
04/20/2022
Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD
Dr Stefanacci explains how changes in our clinical pathways will greatly expand our treatment options, providing significant improvement in both clinical and financial outcomes. 
Dr Stefanacci explains how changes in our clinical pathways will greatly expand our treatment options, providing significant improvement in both clinical and financial outcomes. 
Dr Stefanacci explains how...
04/20/2022
Journal of Clinical Pathways
Trending From ACCC
04/20/2022
Association of Community Cancer Centers
ACCC Community Oncology Research Institute (ACORI) works to establish clinical trials as a standard of care in treatment plans and will enable community oncology programs and their multidisciplinary teams to access the tools, knowledge...
ACCC Community Oncology Research Institute (ACORI) works to establish clinical trials as a standard of care in treatment plans and will enable community oncology programs and their multidisciplinary teams to access the tools, knowledge...
ACCC Community Oncology Research...
04/20/2022
Journal of Clinical Pathways
Pharma Insights
04/20/2022
Elizabeth Oyekan, PharmD, FCSHP, CPHQ
Marissa Baker-Wagner, MPH
Ronaé McLin, MPH
Dr Okeyan and colleagues discuss key areas where big data analytics are being leveraged in health care, the implications to payer and pharma stakeholders, and key considerations for success.
Dr Okeyan and colleagues discuss key areas where big data analytics are being leveraged in health care, the implications to payer and pharma stakeholders, and key considerations for success.
Dr Okeyan and colleagues ...
04/20/2022
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement